(Q36839629)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Bengt Skoog

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jan Fagius

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Sten Fredrikson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Anne-Marie Landtblom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Clas Malmeström

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

H Tedeholm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

V Lisovskaja

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Hillert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C Dahle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C Martin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

F Piehl

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

B Runmarker

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

L Stawiarz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

M Vrethem

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

O Nerman

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

O Andersen

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

1 reference

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

765-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

17 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Increasing age at disability milestones among MS patients in the MSBase Registry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Natural history of multiple sclerosis: long-term prognostic factors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Evidence for a two-stage disability progression in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Disability profile of MS did not change over 10 years in a population-based prevalence cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Defining the clinical course of multiple sclerosis: Results of an international survey

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

29 September 2017

https://api.crossref.org/works/10.1177%2F1352458512463764

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Selection bias in observational studies: out of control?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Immortal time bias in the study of effectiveness of interferon-beta in multiple sclerosis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652599

Changes in the ascertainment of multiple sclerosis

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458512463764

Comorbidity, socioeconomic status and multiple sclerosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458512463764

Short-term prognosis in early relapsing-remitting multiple sclerosis

21 January 2018

1 reference

12 December 2020

A prospective study on the prognosis of multiple sclerosis

1 reference

12 December 2020

Restricted dissemination of clinically defined attacks in an MS incidence material

1 reference

12 December 2020

Prediction of outcome in multiple sclerosis based on multivariate models

1 reference

12 December 2020

Prognostic factors for survival in multiple sclerosis

1 reference

12 December 2020

Discrepancies in the interpretation of clinical symptoms and signs in the diagnosis of multiple sclerosis. A proposal for standardization

1 reference

12 December 2020

Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients

1 reference

12 December 2020

New natural history of interferon-β-treated relapsing multiple sclerosis

1 reference

12 December 2020

Prognostic factors of multiple sclerosis in Lebanon

1 reference

12 December 2020

Identifiers

DOI

10.1177/1352458512463764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

PubMed publication ID

23124789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23124789%20AND%20SRC:MED&resulttype=core&format=json